IP Library Granted Patent US 9,504,709
Granted Patent B2
US 9,504,709 · App. 15/017,772 · Granted Nov 29, 2016

Sodium nitrite-containing pharmaceutical compositions

Inventors: Craig Sherman (Scottsdale, AZ); Anthony James Lepine (Greendale, WI); Catherine Marie Smith (Grafton, WI); Kevin Robert Wirtz (Belgium, WI); Erich Schulze (Mission Viejo, CA)
Assignee: Hope Medical Enterprises, Inc.
A61K33/00A61K31/17A61K31/4418A61K31/4709A61K31/519C01B21/50Y10T436/204998
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,504,709
App. No.
15/017,772
Granted
Nov 29, 2016
Kind
B2
Abstract

Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

Claims (7)

1. A method for treating, preventing, or reducing the risk of a hospital-acquired infection comprising administering to a subject having or at risk for having a hospital-acquired infection a therapeutically effective amount of sodium nitrite which contains no greater than 0.02% by weight of sodium carbonate, contains no greater than 10 ppm of an anti-caking agent, has a loss on drying of no greater than 0.25% by weight, wherein the water content is no greater than 0.5% by weight, wherein the heavy metal content is no greater than 10 ppm, contains no greater than 0.4% by weight of sodium nitrate, contains no greater than 0.005% by weight of insoluble matter, contains no greater than 0.005% by weight of chloride, contains no greater than 0.01% by weight of sulfate, contains no greater than 0.001% by weight of iron, contains no greater than 0.01% by weight of calcium, contains no greater than 0.005% by weight of potassium, contains no greater than 0.05 ppm of mercury, contains no greater than 2 ppm of aluminum, contains no greater than 3 ppm of arsenic, contains no greater than 0.003% by weight of selenium, contains no greater than 5000 ppm of ethanol, contains no greater than 3000 ppm methanol, wherein the total non-volatile organic carbon content is no greater than 10 ppm, and contains no greater than 0.25 EU/mg of bacterial endotoxins.

2. The method of claim 1 , wherein the sodium nitrite contains no less than 97% by weight of sodium nitrite.

3. The method of claim 1 , wherein the sodium nitrite contains no less than 98% by weight of sodium nitrite.

4. The method of claim 1 , wherein the sodium nitrite contains no less than 99.8% by weight of sodium nitrite as measured by Ion Chromatography analysis.

5. The method of claim 1 , wherein the sodium nitrite is a white solid.

6. The method of claim 1 , wherein a 10% aqueous solution of the sodium nitrite at 25 has a pH value between 8 and 9.

7. method of claim 1 , wherein the sodium nitrite has total aerobic count of microbial load of no greater than 100 CFU/g and has total yeast and mold count of no greater than 20 CFU/g.

Continuity (6)
Division 14547245 · Nov 19, 2014
Division 14042783 · Oct 1, 2013
Division 12703448 · Feb 10, 2010
Provisional Application 61224021 · Jul 8, 2009
Provisional Application 61151820 · Feb 11, 2009
Related Publication 20160151413A1 · Jun 2, 2016